MD-3 (DiNonA)

N/A

Report date: 2025/06/11 11:05:45

Base Information

Drug NameMD-3 (DiNonA)
Drug Alias NameMD3 antibody therapeutics (DiNonA)DNP-003KDDF-201212-01
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Chimeric monoclonal antibody
Mechanisms of ActionImmunosuppressantsIntercellular adhesion molecule-1 inhibitors
TargetsIntercellular adhesion molecule-1
Therapy Area/IndicationsIslet Cell Transplant RejectionRejection of liver transplantation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSeoul National University College Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesSeoul National University College Of MedicineDinona
Inactive CompaniesN/A
Active IndicationsIslet Cell Transplant Rejection
Inactive IndicationsRejection of liver transplantation

Other Information

ATC CodeN/A
Related LinksN/A